🇺🇸 FDA
Patent

US 6210670

Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin

expired A61KA61K38/00A61P

Quick answer

US patent 6210670 (Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin) held by Protein Design Labs, Inc. expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Protein Design Labs, Inc.
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
55
CPC classes
A61K, A61K38/00, A61P, A61P11/00, A61P17/00